Objectives A laparoscopic approach improves short‐term outcomes and maintains long‐term outcomes compared to an open approach. In turn, the recent development of robotic surgery raises the question whether it performs as well as laparoscopic surgery. The aim of this study was to compare the short‐ and long‐term outcomes of laparoscopic liver resection (LLR) and robotic liver resection (RLR) for malignancies. Method From 2011 to 2017, the study population included 111 patients in the LLR group and 61 in the RLR group. Short‐ and long‐term outcomes were compared before and after propensity score matching (PSM). Results Operative mortality rate was nil. The intraoperative blood transfusion rate was higher during RLR (15% vs. 2%, p = 0.0009). Major morbidity and hospital stay were not different between the two groups. The resection margin width (LLR 7 mm vs. RLR 10 mm, p = 0.13) and R1 resection rates (resection margin width < 1 mm; LLR 15% vs. RLR 11%, p = 0.49) were similar. After PSM (55 patients in each group), the blood transfusion, major morbidity, hospital stay and R1 resection were similar between the two groups. When considering the largest subset of patients with hepatocellular carcinoma including 114 patients (66%), the 3‐year overall survival rate was 80% in the LLR group and 97% in the RLR group (p = 0.10) and remained similar after PSM (p = 0.27). The 3‐year recurrence‐free survival rate was 50% in the LLR group and 64% in the RLR group (p = 0.30) and remained similar after PSM (p = 0.26). Conclusions No differences were found in blood transfusion, incidence of positive resection margins and long‐term outcomes between the two techniques. RLR does not compromise short‐term and oncologic outcomes in patients with liver cancers.
Myxomatous mitral regurgitation (type II Carpentier's functional classification) affects about 1-2% of the population. This represents a very common indication for valve surgery resulting in a low percentage of repairs compared to replacement which is actually performed. In the last decades, several methods for mitral valve repair have been developed, to make the surgical feasibility easier, improve the long-term follow-up thus avoiding the need for reoperations. A very interesting method is represented by the combination of various valve repair techniques, depending on the involvement of the anterior, posterior, or both leaflets, and the use of PTFE artificial chordae tendineae when excessive chordal elongation or rupture due to myxomatous degeneration co-exists. The aim of this review is to summarize the evolution of these techniques from the beginning till now.
Symptomatic pelvic organ prolapse (POP) can have an important impact on general health-related quality of life (QoL) and interfere, as a disability, with physical mobility, pain, emotional reaction, social isolation, energy and sleep (1). The impact of pelvic floor disorders on health related QoL is similar to the impact of other chronic and debilitating conditions as stroke, cancer, diabetes and dementia (2). Lifetime risk of undergoing at least one surgical procedure for prolapse and urinary incontinence (UI) is 11-18 % by the age of 79 years old and the reoperation rate for recurrence of these disorders is 29,2% (3). Over the next 30 years, demand for services to care for female pelvic organ diseases will increase at twice the rate of growth of the same population and the number of surgeries for UI and POP will increase substantially over the next 40 years (4). The high prevalence of POP results in high socio-economic costs and a significant impact on quality of life of these patients.Literature review in terms of colorectal pathology brings out some important observations: there is an unacceptable percentage of obstructed defecation syndrome (ODS) not resolved with conventional surgical procedures. The impact of surgical correction of prolapse symptoms on ODS remains unclear. There are few studies that explore this issue and the data that exist are mixed. Several studies suggest an improvement in constipation levels (5), while others demonstrated a worsening in symptoms or a significant degree of new-onset constipation (6). Furthermore, pre-operative clinical and instrumental evaluations rarely include anatomical-functional examinations of the rectum, thus neglecting that the rectum is one of the pelvic organs that has a high impact in pelvic dynamic, being daily more subjected to mechanical strains. If ODS persists or is created de novo in patients undergoing surgery for POP, this often results in intense straining which represents a daily mechanical stress on all the pelvic organs and supporting structures. We do not exclude that this could be a major cause of the high rate of relapse after conventional surgery. For these reasons, we believe that correcting ODS is a prerequisite in order to avoid relapses and im-
Background: Despite improved overall outcomes rejection continues to occur frequently after pancreas transplantation. Objective: To review the literature and to provide a state-of-the-art assessment of current practice and developments of immunosuppressive regimens in pancreas transplantation. Methods: The English literature was reviewed. Relevant articles were retrieved and analysed. Results: Induction therapy is used in approximately 90% of the transplants, with T-cell depleting antibodies being the prevalent therapy (>90%). Despite the initial enthusiasm on steroid-free regimens, maintenance protocols continue to be mostly based on a combination of steroids, tacrolimus, and mycophenolate mofetil. Tacrolimus is used in the majority of recipients. Sirolimus is rarely used at the time of transplant and is introduced later on in approximately 10% of the recipients, mostly in the context of a switching strategy to address the side effects of calcineurin inhibitors. The overall quality of published studies was quite low, because of the retrospective design, the heterogeneity of study groups with respect to PTx categories, the inclusion of mixed recipient categories with respect to immunologic risk profile, and the use of non-standardized concurrent immunosuppressive therapies. In addition, most reported studies are clearly underpowered, and treatment outcomes were not standardized. Conclusions: Since approximately two decades immunosuppression in pancreas transplantation mostly consists in induction with depleting antibodies and maintenance therapy using a combination of steroids, tacrolimus, and mycophenolate mofetil. While true novelty would be very much needed, this review confirms the wide use and the clinical efficacy of this regimen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.